Management of Adrenal Incidentalomas
Publication Date: June 15, 2023
Last Updated: August 2, 2023
General remarks
R.1.1
We recommend that patients with adrenal incidentalomas are discussed in a multidisciplinary expert team meeting, if at least one of the following criteria is met:
- Imaging is not consistent with a benign lesion.
- There is evidence of hormone excess (including mild autonomous cortisol secretion [MACS] in patients with clinically relevant comorbidities potentially attributable to cortisol).
- Adrenal surgery is considered.
- Evidence of significant tumor growth during follow-up imaging.
1846524
Assessment of the risk of malignancy
R.2.1
We recommend aiming to establish with the highest possible certainty if an adrenal mass is benign or malignant at the time of initial detection. (, )
1846524
Overview
Title
Management of Adrenal Incidentalomas
Authoring Organization
European Society of Endocrinology
To continue viewing this pocket guide, please purchase it.
My Library
added to your library.
Grading Table
Feedback